Dynavax Technologies Corporation (0IDA.L)
| Previous close | 9.20 |
| Open | 9.13 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 9.12 - 9.14 |
| 52-week range | 9.12 - 9.14 |
| Volume | 2,950 |
| Avg. volume | N/A |
| Market cap | 193.192M |
| Beta (5Y monthly) | 1.23 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.58 |
| Earnings date | 04 Aug 2021 - 09 Aug 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
Why COVID Vaccine Stocks Dynavax, Novavax, and Vaxart Are Sinking Today
Dynavax Technologies (NASDAQ: DVAX) stock was down 6.3% as of 11:26 a.m. EDT, while shares of Novavax (NASDAQ: NVAX) and Vaxart (NASDAQ: VXRT) were falling 7.8% and 10.6%, respectively. The declines for the biotech stocks appear to merely be run-of-the-mill volatility on a day when the overall stock market was down. Sales of its Heplisav-B hepatitis B vaccine were negatively impacted by the COVID-19 pandemic.
- Simply Wall St.
Is Dynavax Technologies (NASDAQ:DVAX) Using Debt In A Risky Way?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
- Motley Fool
Why Dynavax Stock Is Rising Today
What happened Shares of Dynavax Technologies (NASDAQ: DVAX) were up by 3.6% as of 11:38 a.m. EDT on Thursday after having gained as much as 6.9% earlier in the session. The stock's rise came following the company's announcement that it has signed a deal with Bavarian Nordic to market and distribute its hepatitis B vaccine Heplisav B in Germany.
